Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Jaewon James Lee

Matched on ORCID iD 0000-0002-5677-2398; OpenAlex author ID A5052875627. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2020: 1 paper · 2021: 4 papers · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 10

  1. Limitations of GATA6 and CK5 as surrogate markers for molecular subtyping in pancreatic cancer. Co-author DOI 10.1016/j.hpb.2026.08.001↗
  2. Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.suc.2024.04.001↗
  3. Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006416↗
  4. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Co-author DOI 10.1038/s41467-022-31376-3↗
  5. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1053/j.gastro.2022.02.024↗
  6. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Co-author DOI 10.1038/s41416-021-01350-9↗
  7. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution Co-author DOI 10.1101/2021.04.13.439717↗
  8. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Co-author DOI 10.1158/1078-0432.ccr-20-2667↗
  9. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Co-author DOI 10.1158/1078-0432.ccr-20-3925↗
  10. Diversity Across the Pancreatic Ductal Adenocarcinoma Disease Spectrum Revealed by Network-Anchored Functional Genomics Co-author DOI 10.1101/2020.09.17.302034↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jen Jen Yeh · 3 shared papers, 2024–2026 · strength 0.93
  2. Vincent Bernard · 6 shared papers, 2021–2022 · strength 0.70
  3. Anirban Maitra · 6 shared papers, 2020–2022 · strength 0.66
  4. Maria E. Monberg · 5 shared papers, 2021–2022 · strength 0.59
  5. Alexander Semaan · 5 shared papers, 2021–2022 · strength 0.59
  6. Paola A. Guerrero · 5 shared papers, 2020–2022 · strength 0.54
  7. Naim U. Rashid · 2 shared papers, 2024–2026 · strength 0.47
  8. Matthew H. G. Katz · 3 shared papers, 2021–2022 · strength 0.36
  9. Alina Cornelia Iuga · 1 shared paper, 2026 · strength 0.29
  10. Saryn Doucette · 1 shared paper, 2026 · strength 0.29
  11. Mohammed Aldakkak · 1 shared paper, 2026 · strength 0.29
  12. Douglas B. Evans · 1 shared paper, 2026 · strength 0.29
  13. Ken Chen · 2 shared papers, 2021–2022 · strength 0.26
  14. Cullen M. Taniguchi · 2 shared papers, 2021–2022 · strength 0.23
  15. Daniel Lin · 2 shared papers, 2021–2022 · strength 0.23
  16. Manoop S. Bhutani · 2 shared papers, 2021 · strength 0.22
  17. Brian R. Weston · 2 shared papers, 2021 · strength 0.22
  18. Hannah E. Trembath · 1 shared paper, 2024 · strength 0.18
  19. Joseph F. Kearney · 1 shared paper, 2024 · strength 0.18
  20. Abagail M. Delahoussaye · 1 shared paper, 2022 · strength 0.12
  21. Emily G. Caggiano · 1 shared paper, 2022 · strength 0.12
  22. Carolina J. García García · 1 shared paper, 2022 · strength 0.12
  23. Natividad Roberto Fuentes · 1 shared paper, 2022 · strength 0.12
  24. Tara N. Fujimoto · 1 shared paper, 2022 · strength 0.12
  25. Meifang Yu · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.